Combination drug

Details Combination drug Combination drug

A - Human Necessities

61

K

A61K 31/155 (2006.01) A61K 31/496 (2006.01) A61K 31/5025 (2006.01) A61K 31/522 (2006.01) A61K 45/00 (2006.01) A61P 1/00 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) A61P 5/00 (2006.01) A61P 5/50 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2498423

It is intended to provide a drug comprising a combination of a dipeptidyl peptidase IV (DPPIV) inhibitor with biguanide characterized by potentiating the effect of activated glucagon-like peptide-1 (GLP-1) in blood and/or activated glucagon-like peptide-2 (GLP-2) in blood.

L'invention concerne un médicament contenant une combinaison d'un inhibiteur de dipeptidyle peptidase IV (DPPIV) avec de la biganide caractérisé en ce qu'il potentialise l'effet, dans le sang, du peptide-1 de type glucagone activé (GLP-1) et/ou du peptide-2 de type glucagone activé (GLP-2).

Affiliated with

Also associated with

Rating

Combination drug does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination drug will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1393983